Commentary: Remote learning creates more room at the table

por Feldman, Hope A., Antonoff, Mara B.
Publicado 2021

Chyloptysis as a delayed sequela of penetrating thoracic trauma

por Mitchell, Kyle G., Feldman, Hope, Meyers, Bryan F., Antonoff, Mara B.
Publicado 2021

Current Surgical Indications for Non-Small-Cell Lung Cancer

por Deboever, Nathaniel, Mitchell, Kyle G., Feldman, Hope A., Cascone, Tina, Sepesi, Boris
Publicado 2022

Outcomes after thymectomy in non-thymomatous myasthenia gravis

por Deboever, Nathaniel, Xu, Ying, Feldman, Hope A., Woodman, Karin H., Chen, Merry, Shih, Ya-Chen Tina, Rajaram, Ravi
Publicado 2023

Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity

por Feldman, Hope A., Zhou, Nicolas, Deboever, Nathanial, Hofstetter, Wayne, Mehran, Reza, Rajaram, Ravi, Rice, David, Roth, Jack A., Sepesi, Boris, Swisher, Stephen, Vaporciyan, Ara, Walsh, Garrett, Godoy, Myrna, Strange, Chad, Antonoff, Mara B.
Publicado 2022

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC

por Antonoff, Mara B., Feldman, Hope A., Mitchell, Kyle G., Farooqi, Ahsan, Ludmir, Ethan B., Hofstetter, Wayne L., Mehran, Reza J., Rajaram, Ravi, Rice, David C., Sepesi, Boris, Swisher, Stephen G., Walsh, Garrett L., Gandhi, Saumil, Gomez, Daniel R., Vaporciyan, Ara A.
Publicado 2022

Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations

por Deboever, Nathaniel, Zhou, Nicolas, McGrail, Daniel J., Tomczak, Katarzyna, Oliva, Jacqueline L., Feldman, Hope A., Parra, Edwin, Zhang, Jianjun, Lee, Percy P., Antonoff, Mara B., Hofstetter, Wayne L., Mehran, Reza J., Rajaram, Ravi, Rice, David C., Roth, Jack A., Swisher, Stephen S., Vaporciyan, Ara A., Altan, Mehmet, Weissferdt, Annikka, Tsao, Anne S., Haymaker, Cara L., Sepesi, Boris
Publicado 2023

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

por Cascone, Tina, Leung, Cheuk H., Weissferdt, Annikka, Pataer, Apar, Carter, Brett W., Godoy, Myrna C. B., Feldman, Hope, William, William N., Xi, Yuanxin, Basu, Sreyashi, Sun, Jing Jing, Yadav, Shalini S., Rojas Alvarez, Frank R., Lee, Younghee, Mishra, Aditya K., Chen, Lili, Pradhan, Monika, Guo, Haiping, Sinjab, Ansam, Zhou, Nicolas, Negrao, Marcelo V., Le, Xiuning, Gay, Carl M., Tsao, Anne S., Byers, Lauren Averett, Altan, Mehmet, Glisson, Bonnie S., Fossella, Frank V., Elamin, Yasir Y., Blumenschein, George, Zhang, Jianjun, Skoulidis, Ferdinandos, Wu, Jia, Mehran, Reza J., Rice, David C., Walsh, Garrett L., Hofstetter, Wayne L., Rajaram, Ravi, Antonoff, Mara B., Fujimoto, Junya, Solis, Luisa M., Parra, Edwin R., Haymaker, Cara, Wistuba, Ignacio I., Swisher, Stephen G., Vaporciyan, Ara A., Lin, Heather Y., Wang, Jing, Gibbons, Don L., Jack Lee, J., Ajami, Nadim J., Wargo, Jennifer A., Allison, James P., Sharma, Padmanee, Kadara, Humam, Heymach, John V., Sepesi, Boris
Publicado 2023